Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma
Background: Identification of high-risk patients with multiple myeloma (MM) is important for improving treatment outcomes. Efforts to identify significant prognostic markers are unremitting. Angiogenesis plays an important mechanism in the progression of MM. One of the mediators of this angiogenic p...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Kasr Al-Ainy Center of Clinical Oncology and Nuclear Medicine
2021-06-01
|
Series: | Research in Oncology |
Subjects: | |
Online Access: | https://resoncol.journals.ekb.eg/article_159690_85cd8abf0aa1304d98bca11b57a25c20.pdf |